Personal information

No personal information available

Activities

Collapse all

Employment (2)

INSERM: Villejuif, Île-de-France, FR

(U1015)
Employment
Source: Self-asserted source
Safae TERRISSE

Hôpital Saint-Louis Service d'Oncologie Médicale: Paris, Île-de-France, FR

MD, PhD (Medical Oncology)
Employment
Source: Self-asserted source
Safae TERRISSE

Works (28)

Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.

Nature communications
2024-02 | Journal article
DOI: 10.1038/s41467-024-45357-1
PMID: 38395948
PMC: PMC10891084
Contributors: Alves Costa Silva C; Piccinno G; Suissa D; Bourgin M; Schreibelt G; Durand S; Birebent R; Fidelle M; Sow C; Aprahamian F et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Is it possible to delay stereotactic radiotherapy of brain metastasis of lung cancer?

2023-08 | Preprint
DOI: 10.21203/rs.3.rs-3279607/v1
PPR: PPR709224
Contributors: Musset X; Guillerm S; Gounant V; Quero L; Dumont C; Terrisse S; Bollet M; Zalcman G; Hennequin C
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.

Science (New York, N.Y.)
2023-06 | Journal article
DOI: 10.1126/science.abo2296
PMID: 37289890
Contributors: Fidelle M; Rauber C; Alves Costa Silva C; Tian AL; Lahmar I; de La Varende AM; Zhao L; Thelemaque C; Lebhar I; Messaoudene M et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

2023-05 | Preprint
DOI: 10.21203/rs.3.rs-2924093/v1
PPR: PPR661566
Contributors: ALVES-COSTA-SILVA C; Bourgin M; Piccinno G; Schreibelt G; Durand S; Fidelle M; Sow C; Birebent R; Aprahamian F; Manghi P et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Impact of microbiota on breast cancer hormone therapy.

Cell stress
2023-03 | Journal article
DOI: 10.15698/cst2023.03.277
PMID: 36926118
PMC: PMC10012050
Contributors: Terrisse S; Zitvogel L; Kroemer G
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
2023-01 | Journal article
DOI: 10.1016/j.jtho.2022.12.018
PMID: 36646211
Contributors: Aldea M; Marinello A; Duruisseaux M; Zrafi W; Conci N; Massa G; Metro G; Monnet I; Gomez Iranzo P; Tabbo F et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy.

Microbial cell (Graz, Austria)
2022-11 | Journal article
DOI: 10.15698/mic2022.12.787
PMID: 36483309
PMC: PMC9714294
Contributors: Terrisse S; Zitvogel L; Kroemer G
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.

Cancer discovery
2022-04 | Journal article
DOI: 10.1158/2159-8290.cd-21-0999
PMID: 34930787
Contributors: Yonekura S; Terrisse S; Alves Costa Silva C; Lafarge A; Iebba V; Ferrere G; Goubet AG; Fahrner JE; Lahmar I; Ueda K et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.

Cancer discovery
2022-04 | Journal article
DOI: 10.1158/2159-8290.cd-21-1441
PMID: 35179201
PMC: PMC9394394
Contributors: Fahrner JE; Lahmar I; Goubet AG; Haddad Y; Carrier A; Mazzenga M; Drubay D; Alves Costa Silva C; Lyon COVID Study Group; de Sousa E et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer

Journal for ImmunoTherapy of Cancer
2022-03 | Journal article
DOI: 10.1136/jitc-2021-004191
Contributors: Safae Terrisse; Anne-Gaelle Goubet; Kousuke Ueda; Andrew Maltez Thomas; Valentin Quiniou; Cassandra Thelemaque; Garett Dunsmore; Emmanuel Clave; Melissa Gamat-Huber; Satoru Yonekura et al.
Source: check_circle
Crossref

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.

Nature medicine
2022-02 | Journal article
DOI: 10.1038/s41591-021-01655-5
PMID: 35115705
PMC: PMC9330544
Contributors: Derosa L; Routy B; Thomas AM; Iebba V; Zalcman G; Friard S; Mazieres J; Audigier-Valette C; Moro-Sibilot D; Goldwasser F et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?

Cancer discovery
2021-08 | Journal article
DOI: 10.1158/2159-8290.cd-21-0236
PMID: 34400407
Contributors: Derosa L; Routy B; Desilets A; Daillère R; Terrisse S; Kroemer G; Zitvogel L
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.

Cancers
2021-08 | Journal article
DOI: 10.3390/cancers13153887
PMID: 34359788
PMC: PMC8345514
Contributors: Refeno V; Lamuraglia M; Terrisse S; Bonnet C; Dumont C; Doucet L; Pouessel D; Culine S
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Cell death and differentiation
2021-07 | Journal article
DOI: 10.1038/s41418-021-00817-9
PMID: 34230615
PMC: PMC8259103
Contributors: Goubet AG; Dubuisson A; Geraud A; Danlos FX; Terrisse S; Silva CAC; Drubay D; Touri L; Picard M; Mazzenga M et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.

Cell death & disease
2021-06 | Journal article
DOI: 10.1038/s41419-021-03864-9
PMID: 34108446
PMC: PMC8190068
Contributors: Joseph A; Chen H; Anagnostopoulos G; Montégut L; Lafarge A; Motiño O; Castedo M; Maiuri MC; Clément K; Terrisse S et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

The polarity and specificity of SARS-CoV2-specific T lymphocyte responses determine disease susceptibility

2021-06 | Preprint
DOI: 10.1101/2021.06.18.21258477
PPR: PPR359896
Contributors: Fahrner J; Carrier A; De Sousa E; Drubay D; Dubuisson A; Geraud A; Goubet A; Ferrere G; Haddad Y; Lahmar I et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment.

Cell death and differentiation
2021-05 | Journal article
DOI: 10.1038/s41418-021-00784-1
PMID: 33963313
PMC: PMC8408230
Contributors: Terrisse S; Derosa L; Iebba V; Ghiringhelli F; Vaz-Luis I; Kroemer G; Fidelle M; Christodoulidis S; Segata N; Thomas AM et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

2021-05 | Preprint
DOI: 10.1101/2021.04.26.21250357
PPR: PPR334768
Contributors: Goubet A; Dubuisson A; Geraud A; Danlos F; Terrisse S; Alves Costa Silva C; Drubay D; Touri L; Picard M; Mazzenga M et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?

Therapeutic Advances in Medical Oncology
2021-01 | Journal article
DOI: 10.1177/17588359211051870
Part of ISSN: 1758-8359
Part of ISSN: 1758-8359
Source: Self-asserted source
Safae TERRISSE

Immunodynamics of explanted human tumors for immuno-oncology.

EMBO molecular medicine
2020-12 | Journal article
DOI: 10.15252/emmm.202012850
PMID: 33372722
PMC: PMC7799366
Contributors: Dubuisson A; Fahrner JE; Goubet AG; Terrisse S; Voisin N; Bayard C; Lofek S; Drubay D; Bredel D; Mouraud S et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors.

Oncoimmunology
2020-07 | Journal article
DOI: 10.1080/2162402x.2020.1794423
PMID: 32934888
PMC: PMC7466864
Contributors: Daillère R; Routy B; Goubet AG; Cogdill A; Ferrere G; Alves-Costa Silva C; Fluckiger A; Ly P; Haddad Y; Pizzato E et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non-Small Cell Lung Cancer.

Cancer immunology research
2020-07 | Journal article
DOI: 10.1158/2326-6066.cir-20-0196
PMID: 32847937
Contributors: Hakozaki T; Richard C; Elkrief A; Hosomi Y; Benlaïfaoui M; Mimpen I; Terrisse S; Derosa L; Zitvogel L; Routy B et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.

European urology
2020-05 | Journal article
DOI: 10.1016/j.eururo.2020.04.044
PMID: 32376136
Contributors: Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical Trials.

JAMA oncology
2020-02 | Journal article
DOI: 10.1001/jamaoncol.2019.4097
PMID: 31830233
PMC: PMC6990736
Contributors: Terrisse S; Karamouza E; Parker CC; Sartor AO; James ND; Pirrie S; Collette L; Tombal BF; Chahoud J; Smeland S et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Primary adenocarcinoma of the seminal vesicle.

Rare tumors
2017-10 | Journal article
DOI: 10.4081/rt.2017.7074
PMID: 29081928
PMC: PMC5643883
Contributors: Terrisse S; Camblor ME; Vérine J; Gauthier H; Mongiat-Artus P; Culine S
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?

European journal of cancer (Oxford, England : 1990)
2015-12 | Journal article
DOI: 10.1016/j.ejca.2015.11.017
PMID: 26724422
Contributors: Pouessel D; Chevret S; Rolland F; Gravis G; Geoffrois L; Roubaud G; Terrisse S; Boyle H; Chevreau C; Dauba J et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

[Molecular biology of castration-resistant prostate cancer].

Bulletin du cancer
2015-05 | Journal article
DOI: 10.1016/j.bulcan.2015.04.014
PMID: 26028493
Contributors: Doucet L; Terrisse S; Gauthier H; Pouessel D; Le Maignan C; Teixeira L; Culine S
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology
2014-07 | Journal article
DOI: 10.1093/annonc/mdu362
PMID: 25070544
PMC: PMC4207728
Contributors: Chakiba C; Lagarde P; Pissaloux D; Neuville A; Brulard C; Pérot G; Coindre JM; Terrier P; Ranchere-Vince D; Ferrari A et al.
Source: Self-asserted source
Safae TERRISSE via Europe PubMed Central
How many people are using ORCID?